Dingdang Health Reports No New Share Issuance; Buyback Reaches 30.10 Million Shares, 2.28% of Capital Base

Bulletin Express04-09

Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return (dated 9 April 2026) confirming that its issued share capital remains unchanged at 1.32 billion ordinary shares. No treasury shares were outstanding or created during the period.

The company continues to advance its share-repurchase programme. From 25 November 2025 to 9 April 2026, 30.10 million shares have been bought back for cancellation but had not yet been cancelled as at the latest reporting date. This volume represents 2.28% of the outstanding shares authorised for buyback under the mandate approved on 28 May 2025 (total authorisation: 131.95 million shares).

Latest daily action: • 9 April 2026 – 205,500 shares repurchased on the Exchange at HKD 0.97 each, for a total consideration of HKD 0.20 million. • All 205,500 shares are designated for cancellation.

Key programme metrics based on disclosed transactions: • Cumulative repurchases under the mandate: 30.10 million shares. • Price range: HKD 0.80 to HKD 1.21 per share. • Estimated aggregate cash outlay (derived from disclosed unit prices): approximately HKD 32.10 million, implying an average cost of about HKD 1.07 per share.

A moratorium on new share issues or transfers is in effect until 9 May 2026 in accordance with Hong Kong Main Board Rule 10.06(3)(a).

Joint Company Secretary Lam Yiu Por submitted the disclosure, confirming full compliance with Hong Kong listing regulations and related statutory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1160679264?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-09 18:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160679264","market":"us","top_or_hot":-1,"title":"Dingdang Health Reports No New Share Issuance; Buyback Reaches 30.10 Million Shares, 2.28% of Capital Base","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return (dated 9 April 2026) confirming that its issued share capital remains unchanged at 1.32 billion ordinary shares. No treasury shares were outstanding or created during the period.</p>\n<p>The company continues to advance its share-repurchase programme. From 25 November 2025 to 9 April 2026, 30.10 million shares have been bought back for cancellation but had not yet been cancelled as at the latest reporting date. This volume represents 2.28% of the outstanding shares authorised for buyback under the mandate approved on 28 May 2025 (total authorisation: 131.95 million shares).</p>\n<p>Latest daily action:\n• 9 April 2026 – 205,500 shares repurchased on the Exchange at HKD 0.97 each, for a total consideration of HKD 0.20 million.  \n• All 205,500 shares are designated for cancellation.</p>\n<p>Key programme metrics based on disclosed transactions:\n• Cumulative repurchases under the mandate: 30.10 million shares.  \n• Price range: HKD 0.80 to HKD 1.21 per share.  \n• Estimated aggregate cash outlay (derived from disclosed unit prices): approximately HKD 32.10 million, implying an average cost of about HKD 1.07 per share.</p>\n<p>A moratorium on new share issues or transfers is in effect until 9 May 2026 in accordance with Hong Kong Main Board Rule 10.06(3)(a).</p>\n<p>Joint Company Secretary Lam Yiu Por submitted the disclosure, confirming full compliance with Hong Kong listing regulations and related statutory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Reports No New Share Issuance; Buyback Reaches 30.10 Million Shares, 2.28% of Capital Base</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Reports No New Share Issuance; Buyback Reaches 30.10 Million Shares, 2.28% of Capital Base\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-09 18:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return (dated 9 April 2026) confirming that its issued share capital remains unchanged at 1.32 billion ordinary shares. No treasury shares were outstanding or created during the period.</p>\n<p>The company continues to advance its share-repurchase programme. From 25 November 2025 to 9 April 2026, 30.10 million shares have been bought back for cancellation but had not yet been cancelled as at the latest reporting date. This volume represents 2.28% of the outstanding shares authorised for buyback under the mandate approved on 28 May 2025 (total authorisation: 131.95 million shares).</p>\n<p>Latest daily action:\n• 9 April 2026 – 205,500 shares repurchased on the Exchange at HKD 0.97 each, for a total consideration of HKD 0.20 million.  \n• All 205,500 shares are designated for cancellation.</p>\n<p>Key programme metrics based on disclosed transactions:\n• Cumulative repurchases under the mandate: 30.10 million shares.  \n• Price range: HKD 0.80 to HKD 1.21 per share.  \n• Estimated aggregate cash outlay (derived from disclosed unit prices): approximately HKD 32.10 million, implying an average cost of about HKD 1.07 per share.</p>\n<p>A moratorium on new share issues or transfers is in effect until 9 May 2026 in accordance with Hong Kong Main Board Rule 10.06(3)(a).</p>\n<p>Joint Company Secretary Lam Yiu Por submitted the disclosure, confirming full compliance with Hong Kong listing regulations and related statutory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1160679264","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160679264","pubTimestamp":1775731579,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return (dated 9 April 2026) confirming that its issued share capital remains unchanged at 1.32 billion ordinary shares. No...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康报告无新股发行；回购达3010万股，占资本基础的2.28%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. released a Next Day Disclosure Return (dated 9 April 2026) confirming that its issued share capital remains unchanged at 1.32 billion ordinary shares. No treasury shares were outstanding or created during the period.\nThe company continues to advance its share-repurchase programme. From 25 November 2025 to 9 April 2026, 30.10 million shares have been bought back for cancellation but had not yet been cancelled as at the latest reporting date. This volume represents 2.28% of the outstanding shares authorised for buyback under the mandate approved on 28 May 2025 (total authorisation: 131.95 million shares).\nLatest daily action:\n• 9 April 2026 – 205,500 shares repurchased on the Exchange at HKD 0.97 each, for a total consideration of HKD 0.20 million.  \n• All 205,500 shares are designated for cancellation.\nKey programme metrics based on disclosed transactions:\n• Cumulative repurchases under the mandate: 30.10 million shares.  \n• Price range: HKD 0.80 to HKD 1.21 per share.  \n• Estimated aggregate cash outlay (derived from disclosed unit prices): approximately HKD 32.10 million, implying an average cost of about HKD 1.07 per share.\nA moratorium on new share issues or transfers is in effect until 9 May 2026 in accordance with Hong Kong Main Board Rule 10.06(3)(a).\nJoint Company Secretary Lam Yiu Por submitted the disclosure, confirming full compliance with Hong Kong listing regulations and related statutory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1160679264","isCrawlerRequest":true}